Legal Representation
Attorney
                                            Carole E. DeNatale 
                                        USPTO Deadlines
Application History
10 events| Date | Code | Type | Description | Documents | 
|---|---|---|---|---|
| Feb 24, 2009 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... | 
| Feb 24, 2009 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... | 
| Sep 30, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Jul 29, 2008 | DOCK | D | ASSIGNED TO EXAMINER | Loading... | 
| Jul 29, 2008 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... | 
| Jul 29, 2008 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... | 
| Jul 29, 2008 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... | 
| Jun 11, 2008 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... | 
| Apr 19, 2008 | MDSC | O | NOTICE OF DESIGN SEARCH CODE MAILED | Loading... | 
| Apr 18, 2008 | NWAP | I | NEW APPLICATION ENTERED | Loading... | 
Detailed Classifications
                                                Class 039
                                            
                                        Contract manufacturing of prescription pharmaceutical and healthcare products for others, namely, packaging and repackaging of prescription pharmaceutical and healthcare products to the order and specification of others; storage of prescription pharmaceutical and healthcare products and packaging and repackaging of prescription pharmaceutical and healthcare products for transportation; manufacture of prescription pharmaceutical and healthcare products to the order and/or specification of others; and development of and providing quality assurance services in the field of prescription pharmaceutical and healthcare products
                                        
                                                    
                                                    First Use Anywhere: 
Nov 12, 2007                                                    
                                                
                                                
                                                    
                                                    First Use in Commerce: 
Nov 12, 2007                                                    
                                                
                                        Additional Information
                                                
                                                Design Mark
                                            
                                        The mark consists of DRAXIS (underlined) followed by words PHARMA and RESPONSIVE OUTSOURCE MANUFACTURING in verticle display.
                                    
                                                
                                                Color Claim
                                            
                                        Color is not claimed as a feature of the mark.
                                    Classification
                                            
                                            International Classes
                                        
                                        
                                                    039